Review Article

Environmental risk assessment of propofol in wastewater: a narrative review of regulatory guidelines

J. Waspe

Corresponding Author

J. Waspe

Specialty Trainee

Department of Anaesthesia and Operating Services, Sheffield Teaching Hospitals NHS Trust, University of Sheffield, UK

Correspondence to: J. Waspe

Email: j.waspe@sheffield.ac.uk

Search for more papers by this author
T. Orr

T. Orr

Consultant

Department of Anaesthesia and Operating Services, Sheffield Teaching Hospitals NHS Trust, University of Sheffield, UK

Search for more papers by this author
First published: 25 January 2023

This article is accompanied by an editorial by White et al., Anaesthesia 2023; 78: 282–7.

Summary

Concerns relating to the negative environmental impacts of anaesthesia are increasing, and in recent years, there has been an environmentally motivated trend towards greater use of propofol-based total intravenous anaesthesia. Consequently, the environmental burden of propofol waste and disposal, particularly into wastewater, has gained attention. Current literature reporting levels of propofol in wastewater are scarce and the threat this presents to the environment is unclear. We review the regulatory requirements for conducting an environmental risk assessment, with a focus on the process for analysing whether drugs or drug metabolites cause harm to aquatic species. Furthermore, we present a profile for the aquatic toxicity of propofol based on available data and discuss the implications of this for future practice.

Volume78, Issue3

March 2023

Pages 337-342